HIV specialist and leading infectious diseases physician John G. Bartlett, MD, doesn’t mince words when you ask him about what his AIDS patients faced in the early days of the epidemic.
“They were the scourge of society – people didn’t like them because they were either gay or injection drug users, and there was a fear of contagion, that if you were in the same room with someone with AIDS you might get AIDS… They had diarrhea and dementia and wasting. It was an awful way to die. And besides that, everyone around you hated you. Can you imagine living to die that way?”
Dr. Bartlett became a ray of hope for people living with HIV/AIDS. He directed some of the first clinical trials of new treatments that prevent HIV from replicating, and pioneered the development of dedicated in-patient and out-patient medical care for HIV-infected patients.
In our third interview in a Science Speaks series commemorating 30 years of AIDS, Dr. Bartlett speaks frankly about hiding his treatment of AIDS patients from hospital administrators in the early ‘80s, key scientific breakthroughs over the years, and his views on the President’s Emergency Plan for AIDS Relief (PEPFAR) program moving forward.
U.S. Global AIDS Ambassador Dr. Eric Goosby said today the Obama Administration is in the midst of a “rigorous internal discussion” on responding to the National Institutes of Health-funded study that confirmed treating HIV-positive people with antiretroviral (ARV) drugs dramatically reduces the risk of transmitting the virus. Asked about comments from Dr. Anthony Fauci, Director […]
Helen Epstein is a freelance writer and independent consultant in public health. Her articles have appeared in The New York Review of Books, The New York Times Magazine, Granta and elsewhere. Her book The Invisible Cure: Why we are Losing the Fight against AIDS in Africa was a New York Times notable book of 2007. She has taught public health at Columbia University and Bard College, and has served as a consultant for numerous organizations including UNICEF, The World Bank and Human Rights Watch. John Donnelly interviewed Epstein as part of Science Speaks’ series on the 30th anniversary of the first reports of what would become known as HIV/AIDS. She talked about the role discordant couples and concurrent relationships play in driving the epidemic, a hotly debated issue.
Long-time AIDS activist Gregg Gonsalves is often outspoken, and known for saying things like “I’m holding my nose as I say this, but I miss George W. Bush,” as he was quoted in a New York Times article in 2009 criticizing Obama for his lackluster global AIDS plan that aimed to scale back the push to put more people on antiretroviral medication. He has spent more than two decades working on AIDS to address the U.S. and global epidemics, starting out at ACT UP/Boston in the late 80s. One of many accomplishments, Gonsalves is a founding member of the International Treatment Preparedness Coalition, a network of more than 1,000 people from 125 countries advocating for universal access to HIV/AIDS and tuberculosis (TB) treatment. He was also the first-ever recipient of the $100,000 John M. Lloyd AIDS Leadership Award.
In an interview with Meredith Mazzotta for a Science Speaks blog series commemorating 30 years since the first reports of what would come to be known as HIV/AIDS, Gonsalves speaks up about his personal journey to becoming one of the pandemic’s greatest activists, his upcoming AIDS research, and the panic he feels for future funding for AIDS.
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program released a technical guidance document addressing prevention programs for men who have sex with men (MSM) as part of PEPFAR’s overall prevention strategy on Thursday. Originally to be released at the International AIDS Conference in Vienna in July 2010, the guidance was delayed for nearly a […]
More than 70 countries around the world criminalize same-sex activities, to the detriment of lesbian, gay, bisexual and transgender people around the globe, and hindering their access to HIV prevention and treatment services. That was the message expressed at a Congressional briefing Tuesday afternoon, hosted by the Global Forum on Men who have Sex with […]
In commemoration of HIV Vaccine Awareness Day (May 18), Science Speaks conducted the following interview with Louis Picker, MD, associate director of the Oregon Health & Science University’s Vaccine and Gene Therapy Institute. Dr. Picker led a team of researchers from VGTI, the National Cancer Institute – Frederick, and the International AIDS Vaccine Initiative that reported a promising HIV vaccine approach in the advance online edition of the journal Nature last week.
Investigators gave 24 healthy rhesus macaque monkeys a vaccine for simian immunodeficiency virus (SIV), the monkey equivalent of HIV, containing a genetically modified form of the Rhesus cytomegalovirus, which is used as a “vector,” or a carrier that transfers an infective agent from one host to another. Thirteen of the monkeys responded to the vaccine, with 12 of the monkeys showing no signs of SIV infection 12 months later. Authors say this will significantly contribute to the development of an effective HIV vaccine for humans… Read More
Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, is arguably the U.S. government’s best-known scientist. John Donnelly interviewed Dr. Fauci for Science Speaks’ series on the 30th anniversary since the discovery of a virus that would turn out to be HIV, and he talked about everything from how he first learned of the disease, to his surprise in President George W. Bush’s commitment, to the unmet needs today to fight the pandemic. Read more…
Study results announced this morning unequivocally link early antiretroviral therapy (ART) for HIV-infected persons with a 96.3% less chance of transmitting the virus to an uninfected partner, as well as a decreased risk of contracting tuberculosis (TB), the number one killer of people living with HIV/AIDS. The National Institute of Allergy and Infectious Diseases (NIAID) […]
The following Q & A with Kenyan Ob/Gyn Dr. Elizabeth Anne Bukusi, chief research officer and deputy director of research and training at the Kenya Medical Research Institute, covers topics from microbicide trials and challenges to roll-out and medical male circumcision to condom stock-outs and PEPFAR funding. Dr. Bukusi travelled to the U.S. to speak at an event this week discussing how the U.S. can advance global health through new technologies, hosted by the Global health Technologies Coalition Tuesday on Capitol Hill. Read more…